Cargando…
Growth hormone releasing hormone induces the expression of nitric oxide synthase
Growth hormone releasing hormone (GHRH) and its receptors are expressed in a wide variety of human tumours and established cancer cell lines and are involved in carcinogenesis. In addition, GHRH antagonists exert an antitumour activity in experimental cancer models. Recent studies indicate that the...
Autores principales: | Barabutis, Nektarios, Siejka, Agnieszka, Schally, Andrew V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822627/ https://www.ncbi.nlm.nih.gov/pubmed/20518847 http://dx.doi.org/10.1111/j.1582-4934.2010.01096.x |
Ejemplares similares
-
Involvement of the unfolded protein response in the protective effects of growth hormone releasing hormone antagonists in the lungs
por: Akhter, Mohammad S., et al.
Publicado: (2020) -
Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines
por: Barabutis, N, et al.
Publicado: (2008) -
P53, GHRH, inflammation and cancer
por: Barabutis, Nektarios, et al.
Publicado: (2018) -
Growth Hormone-Releasing Hormone in Diabetes
por: Fridlyand, Leonid E., et al.
Publicado: (2016) -
An antagonist of growth hormone-releasing hormone protects against LPS-induced increase of bronchoalveolar lavage fluid protein concentration
por: Akhter, Mohammad S., et al.
Publicado: (2022)